The updated 2025 anesthesia monitoring guidelines from JSA now state that neuromuscular blockade must be quantitatively assessed, and that before extubation, a Train-of-Four (TOF) ratio exceeding 0.9 ...
UPPSALA, SE / ACCESS Newswire / October 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of EMGINETM, a proprietary software suite for its next-generation ...
"Our mission is to deliver solutions that move with the patient and with the clinician - enabling continuity, insight and safety in every phase of care," said Roy Sakai, President of Nihon Kohden ...
Senzime AB has launched EMGINE, a next-generation software suite for its TetraGraph® platform, aimed at advancing neuromuscular monitoring. This new technology, which will be showcased at the ...
Neuromuscular blockade is an essential component of modern anaesthetic practice, enabling muscle relaxation during surgery and facilitating procedures such as tracheal intubation and minimally ...
The use of rocuronium and sugammadex for reversing neuromuscular blockade increased dramatically over 6 years in patients with moderate and severe renal impairment. The variation in strategy selection ...
Hosted on MSN
California University Hospital System Adopts Senzime’s TetraGraph for Neuromuscular Monitoring
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Senzime AB ( (SE:SEZI)) has provided an ...
Uppsala, Sweden – Sept 9, 2025 – Senzime AB (publ) today announced that the Japanese Society of Anesthesiology (JSA) has published updated clinical guidelines on neuromuscular monitoring. The 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback